B.R.A.I.N. Biotechnology Research And Information Network AG (DE000520) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

BRIEF

published on 08/29/2024 at 07:35, 2 months 23 days ago

BRAIN Biotech AG Reports Robust Cash Position and Forecasts Growth

Financial Results Cash Position Growth Forecast BRAIN Biotech AG BioProducts
PRESS RELEASE

published on 08/29/2024 at 07:30, 2 months 23 days ago

BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
BRAIN Biotech AG reports strong cash position for 9M period, forecasting growth in Q4 FY 23/24. BioProducts segment turnover slightly up, BioScience segment facing decline

Cash Position BRAIN Biotech AG BioScience BioProducts Forecasting
BRIEF

published on 05/29/2024 at 09:05, 5 months 23 days ago

BRAIN Biotech AG Announces Erik de Vries as Senior Business Development Director

Business Development BRAIN Biotech AG Erik De Vries Enzymicals AG Enzymes
PRESS RELEASE

published on 05/29/2024 at 09:00, 5 months 23 days ago

BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
BRAIN Biotech AG appoints Erik de Vries as Senior Business Development Director Enzymes. De Vries will transition from CEO of Enzymicals AG to BRAIN Biotech's Supervisory Board in 2025

Supervisory Board BRAIN Biotech AG Erik De Vries Enzymes Senior Business Development Director
BRIEF

published on 05/28/2024 at 07:35, 5 months 24 days ago

BRAIN Biotech AG Receives Major Milestone Payment and Maintains Year-End Targets

Financial Results Revenue Growth BRAIN Biotech AG Milestone Payment BioProducts Segment
PRESS RELEASE

published on 05/28/2024 at 07:30, 5 months 24 days ago

BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets
BRAIN Biotech AG receives significant milestone payment of € 1.5 million and maintains progress towards year-end goals with strengthened cash position. Half-year results show revenue growth and improved EBITDA

Financial Results EBITDA Revenue Growth BRAIN Biotech AG Milestone Payment
BRIEF

published on 04/16/2024 at 11:25, 7 months 5 days ago

BRAIN Biotech AG Announces Merger to Enhance Structural Efficiency

Merger Biotechnology Corporate Structure BRAIN Biotech AG AnalytiCon Discovery GmbH
PRESS RELEASE

published on 04/16/2024 at 11:20, 7 months 5 days ago

BRAIN Biotech AG takes next step to optimize group structure
BRAIN Biotech AG merges AnalytiCon Discovery GmbH to optimize group structure, simplifying operations and enhancing efficiency. The merger aims to streamline the BRAIN Biotech Group structure

Merger BRAIN Biotech AG AnalytiCon Discovery GmbH Group Structure Simplify
BRIEF

published on 03/14/2024 at 09:05, 8 months 7 days ago

BRAIN Biotech and Partners Launch Sustainable Beverage Project

Innovation Sustainability Agriculture Beverage Industry BRAIN Biotech
PRESS RELEASE

published on 03/14/2024 at 09:00, 8 months 7 days ago

Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
German consortium led by BRAIN Biotech AG develops sustainable non-alcoholic beverages from vine leaves and agricultural side streams in innovative project funded by BMBF

Sustainability Non-alcoholic Beverages BRAIN Biotech AG Agricultural Side Streams Innovation Project

Accesswire

Published on 11/21/2024 at 13:30, 36 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 51 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 6 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE